The inverted pyramid of biomarker-driven trials.

The inverted pyramid of biomarker-driven trials.

Item
http://www.wikidata.org/entity/Q51689988
Aberrations in the epidermal growth factor receptor gene in 958 patients with diverse advanced tumors: implications for therapy.Revisiting clinical trials using EGFR inhibitor-based regimens in patients with advanced non-small cell lung cancer: a retrospective analysis of an MD Anderson Cancer Center phase I population.Testing for oncogenic molecular aberrations in cell-free DNA-based liquid biopsies in the clinic: are we there yet?At the frontier of progress for paediatric oncology: the neuroblastoma paradigm.Targeted approaches to childhood cancer: progress in drug discovery and development.Personalized and precision medicine: integrating genomics into treatment decisions in gastrointestinal malignancies.Feedback activation of AMPK-mediated autophagy acceleration is a key resistance mechanism against SCD1 inhibitor-induced cell growth inhibition.Personalized medicine in oncology: where have we come from and where are we going?
P2860

The inverted pyramid of biomarker-driven trials.

Item
http://www.wikidata.org/entity/Q51689988
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
The inverted pyramid of biomarker-driven trials.
@en
The inverted pyramid of biomarker-driven trials.
@nl
type
label
The inverted pyramid of biomarker-driven trials.
@en
The inverted pyramid of biomarker-driven trials.
@nl
prefLabel
The inverted pyramid of biomarker-driven trials.
@en
The inverted pyramid of biomarker-driven trials.
@nl
P1433
P1476
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P356
P1433
P1476
The inverted pyramid of biomarker-driven trials.
@en
P2860
P304
P31
P356
10.1038/NRCLINONC.2011.113
P407
P433
P478
P50
P577
P698